Candida innate immunity at the mucosa

Research output: Contribution to journalArticlepeer-review

43 Citations (Scopus)
527 Downloads (Pure)


The tremendous diversity in microbial species that colonise the mucosal surfaces of the human body is only now beginning to be fully appreciated. Distinguishing between the behaviour of commensal microbes and harmful pathogens that reside at mucosal sites in the body is a complex, and exquisitely fine-tuned process central to mucosal health. The fungal pathobiont Candida albicans is frequently isolated from mucosal surfaces with an asymptomatic carriage rate of approximately 60% in the human population. While normally a benign member of the microbiota, overgrowth of C. albicans often results in localised mucosal infection causing morbidity in otherwise healthy individuals, and invasive infection that often causes death in the absence of effective immune defence. C. albicans triggers numerous innate immune responses at mucosal surfaces, and detection of C. albicans hyphae in particular, stimulates the production of antimicrobial peptides, danger-associated molecular patterns and cytokines that function to reduce fungal burdens during infection. This review will summarise our current understanding of innate immune responses to C. albicans at mucosal surfaces.
Original languageEnglish
JournalSeminars in Cell and Developmental Biology
Early online date9 Mar 2018
Publication statusE-pub ahead of print - 9 Mar 2018


Dive into the research topics of 'Candida innate immunity at the mucosa'. Together they form a unique fingerprint.

Cite this